Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-15 Option Award | 2023-12-15 4:10 pm | N/A 2033-12-14 | SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director | 38,136 | $0 | 38,136 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 105,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:06 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 4:30 pm | N/A 2032-11-16 | SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director | 46,154 | $0 | 129,747 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:32 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-09 5:56 pm | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-23 5:50 pm | N/A 2032-05-20 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 80,000 (Direct) | View |
| 2021-09-23 Option Award | 2021-09-24 4:21 pm | N/A 2031-09-22 | SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director | 29,126 | $0 | 29,126 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-02 7:13 pm | N/A 2031-06-01 | CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 8:55 pm | N/A 2031-05-19 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-09-16 Option Award | 2020-09-18 4:36 pm | N/A 2030-09-15 | SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director | 15,228 | $0 | 15,228 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 11:45 am | N/A 2030-06-10 | CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 8:53 pm | N/A 2030-05-15 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2019-09-06 Option Award | 2019-09-10 6:37 pm | N/A 2029-09-05 | SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director | 30,928 | $0 | 30,928 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-24 5:17 pm | N/A 2029-05-23 | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 55,000 | $0 | 55,000 (Direct) | View |